TipRanks
Esprinet Spa (IT:PRT)
:PRT
Want to see IT:PRT full AI Analyst Report?

Esprinet Spa (PRT) AI Stock Analysis

7 Followers

Top Page

IT:PRT

Esprinet Spa

(PRT)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - Gpt-5.6Sol)
Rating:63Neutral
Price Target:
€9.00
▲(30.06% Upside)
Action:Reiterated
Date:09/12/26
The score is held back primarily by moderate financial quality: while profitability and cash generation have improved, margins remain very thin, leverage has increased, and cash flows have shown meaningful volatility. Offsetting this, the technical setup is strong with the price above key moving averages and positive momentum signals, and valuation is supportive with a reasonable P/E and a ~4.54% dividend yield.
Positive Factors
Revenue and earnings recovery
The return to positive earnings alongside strong TTM revenue growth indicates a meaningful recovery in operating performance. If sustained, improving scale can support reinvestment, strengthen channel relationships, and provide a better foundation for earnings growth over the next several quarters.
Negative Factors
Very thin profitability
A net margin of roughly 0.5% leaves limited room for pricing pressure, cost inflation, or execution errors to be absorbed. Even with revenue growth, small changes in gross margin or operating costs can materially affect earnings, making sustained profit expansion difficult for this business model.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and earnings recovery
The return to positive earnings alongside strong TTM revenue growth indicates a meaningful recovery in operating performance. If sustained, improving scale can support reinvestment, strengthen channel relationships, and provide a better foundation for earnings growth over the next several quarters.
Read all positive factors

Esprinet Spa (PRT) vs. iShares MSCI Italy ETF (EWI)

Esprinet Spa Business Overview & Revenue Model

Company Description
Esprinet S.p.A., headquartered in Vimercate, Italy, operates as a leading wholesale distributor of information technology (IT) and consumer electronics. Its primary markets include Italy, Spain, Portugal, and other European countries. The company'...
How the Company Makes Money
Esprinet makes money primarily by purchasing technology products from manufacturers and brand vendors and reselling them to business-to-business customers (e.g., resellers, VARs, systems integrators, retailers, and online sellers) at a markup, gen...

Esprinet Spa Financial Statement Overview

Summary
Financials are improving but still moderate. Income statement shows a recovery from a 2023 loss to positive TTM earnings, yet margins remain extremely thin (~0.5% net margin) and revenue has been uneven. Balance sheet risk increased as leverage stepped up (debt/equity rising to ~1.3x), reducing flexibility for a working-capital-intensive distributor. Cash flow is positive and improved in TTM with FCF broadly tracking earnings (~0.88x net income), but historical cash-flow volatility remains a key concern.
Income Statement
56
Neutral
Balance Sheet
52
Neutral
Cash Flow
60
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.45B4.29B4.14B3.99B4.68B4.69B
Gross Profit245.31M235.07M226.94M218.44M242.97M231.89M
EBITDA75.64M71.12M68.82M35.82M86.93M83.05M
Net Income21.52M20.17M21.52M-11.88M47.35M44.18M
Balance Sheet
Total Assets1.86B2.08B2.02B1.84B1.87B1.92B
Cash, Cash Equivalents and Short-Term Investments112.20M230.78M216.35M261.00M172.19M491.47M
Total Debt445.00M278.00M262.28M249.00M265.68M273.81M
Total Liabilities1.49B1.69B1.63B1.47B1.47B1.54B
Stockholders Equity376.85M389.47M389.25M367.41M409.22M386.12M
Cash Flow
Free Cash Flow43.83M45.98M-3.20M154.55M-263.84M15.81M
Operating Cash Flow49.97M49.32M2.77M168.04M-251.41M21.65M
Investing Cash Flow-27.02M-24.55M-5.61M-19.95M-19.06M-17.02M
Financing Cash Flow-89.86M-10.46M-41.80M-59.39M-48.82M-72.09M

Esprinet Spa Technical Analysis

Technical Analysis Sentiment
Positive
Last Price6.92
Price Trends
50DMA
7.45
Positive
100DMA
7.20
Positive
200DMA
6.34
Positive
Market Momentum
MACD
0.20
Positive
RSI
56.62
Neutral
STOCH
31.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:PRT, the sentiment is Positive. The current price of 6.92 is below the 20-day moving average (MA) of 7.90, below the 50-day MA of 7.45, and above the 200-day MA of 6.34, indicating a bullish trend. The MACD of 0.20 indicates Positive momentum. The RSI at 56.62 is Neutral, neither overbought nor oversold. The STOCH value of 31.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:PRT.

Esprinet Spa Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
€6.04B12.8423.43%3.15%6.43%7.10%
71
Outperform
€120.35M11.4319.41%6.25%-4.33%-10.03%
68
Neutral
€1.45B19.3916.11%1.43%10.60%18.44%
63
Neutral
€394.29M18.075.61%4.43%5.37%-0.73%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
44
Neutral
€75.49M-9.51-10.59%―14.99%87.84%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:PRT
Esprinet Spa
7.90
2.45
45.06%
IT:BEC
B&C Speakers S.p.A.
11.20
-4.26
-27.56%
IT:EPH
ePRICE S.p.A.
1.46
-0.53
-26.71%
IT:DLG
De'Longhi S.p.A.
40.32
9.73
31.79%
IT:ETH
Eurotech S.p.A.
1.30
0.27
25.75%
IT:SES
Sesa S.p.A.
93.05
4.95
5.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 12, 2026